The combined therapy Eli Lilly COVID-19 reduces the risk of death and hospitalization by 70%, says the company
Treatment with monoclonal antibodies by Eli Lilly reduced the risk of severe COVID-19, reports the pharmacist
Eli Lilly adds $ 23 billion in market capitalization as investors promise that this will be the amyloid Alzheimer’s drug that works
